Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Allografting

Allogeneic stem cell transplantation and donor lymphocyte infusions for chronic myelomonocytic leukemia

Bone Marrow Transplantation volume 37, pages 1003–1008 (2006)Cite this article

Abstract

Prognosis in chronic myelomonocytic leukemia (CMML) is unfavorable and the optimal therapy remains uncertain. Currently, allogeneic stem cell transplantation is the only known curative therapeutic option. However, the data available are limited and restricted to small retrospective series. There is even less information on the use of donor lymphocyte infusions (DLI) for this disease. We reviewed our experience of allogeneic stem cell transplantation and DLI for adults with CMML. Seventeen consecutive adults underwent allogeneic stem cell transplantation from related (n=14) or unrelated (n=3) donors. Median age was 50 years (range 26–60). Seven patients (41%) demonstrated relapse or persistent disease at a median of 6 months (range 3–55.5). Five patients underwent DLI for morphologic relapse and one for mixed donor chimerism. Two patients achieved durable complete remissions of 15 months each. The overall transplant-related mortality was 41% (n=7). With a median follow-up of 34.5 months, three patients (18%) currently remain alive and in continuous CR. The current study demonstrates a graft-versus-leukemia effect in CMML, both for allogeneic stem cell transplantation and for DLI. Nevertheless, consistent with reported experience of others, overall outcomes remain less than optimal and unpredictable.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Vardiman JW, Harris NL, Brunning RD . The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 2002; 100: 2292–2302.

    Article  CAS  Google Scholar 

  2. Onida F, Kantarjian HM, Smith TL, Ball G, Keating MJ, Estey EH et al. Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients. Blood 2002; 99: 840–849.

    Article  CAS  Google Scholar 

  3. Germing U, Kundgen A, Gattermann N . Risk assessment in chronic myelomonocytic leukemia (CMML). Leukemia Lymphoma 2004; 45: 1311–1318.

    Article  CAS  Google Scholar 

  4. Wattel E, Guerci A, Hecquet B, Economopoulos T, Copplestone A, Mahe B et al. A randomized trial of hydroxyurea versus VP16 in adult chronic myelomonocytic leukemia. Groupe Francais des Myelodysplasies and European CMML Group. Blood 1996; 88: 2480–2487.

    CAS  Google Scholar 

  5. Kroger N, Zabelina T, Guardiola P, Runde V, Sierra J, Van Biezen A et al. Allogeneic stem cell transplantation of adult chronic myelomonocytic leukaemia. A report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Br J Haematol 2002; 118: 67–73.

    Article  Google Scholar 

  6. Mittal P, Saliba RM, Giralt SA, Shahjahan M, Cohen AI, Karandish S et al. Allogeneic transplantation: a therapeutic option for myelofibrosis, chronic myelomonocytic leukemia and Philadelphia-negative/BCR-ABL-negative chronic myelogenous leukemia. Bone Marrow Transplant 2004; 33: 1005–1009.

    Article  CAS  Google Scholar 

  7. Kerbauy DM, Chyou F, Gooley T, Sorror ML, Scott B, Pagel JM et al. Allogeneic hematopoietic cell transplantation for chronic myelomonocytic leukemia. Biol Blood Marrow Transplant 2005; 11: 713–720.

    Article  Google Scholar 

  8. Cox D . Regression models and life-tables. J Roy Statist Soc 1972; 34: 187–220.

    Google Scholar 

  9. Sierra J, Perez WS, Rozman C, Carreras E, Klein JP, Rizzo JD et al. Bone marrow transplantation from HLA-identical siblings as treatment for myelodysplasia. Blood 2002; 100: 1997–2004.

    CAS  Google Scholar 

  10. Castro-Malaspina H, Harris RE, Gajewski J, Ramsay N, Collins R, Dharan B et al. Unrelated donor marrow transplantation for myelodysplastic syndromes: outcome analysis in 510 transplants facilitated by the National Marrow Donor Program. Blood 2002; 99: 1943–1951.

    Article  CAS  Google Scholar 

  11. Onida F, Beran M . Chronic myelomonocytic leukemia: myeloproliferative variant. Curr Hematol Rep 2004; 3: 218–226.

    PubMed  Google Scholar 

  12. Zang DY, Deeg HJ, Gooley T, Anderson JE, Anasetti C, Sanders J et al. Treatment of chronic myelomonocytic leukaemia by allogeneic marrow transplantation. Br J Haematol 2000; 110: 217–222.

    Article  CAS  Google Scholar 

  13. Ho AY, Pagliuca A, Kenyon M, Parker JE, Mijovic A, Devereux S et al. Reduced-intensity allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia with multilineage dysplasia using fludarabine, busulphan, and alemtuzumab (FBC) conditioning. Blood 2004; 104: 1616–1623.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hematology/Internal Medicine, Mayo Clinic, Rochester, MN, USA

    M A Elliott, A Tefferi, W J Hogan, L Letendre, D A Gastineau, S M Ansell, A Dispenzieri, M A Gertz, S R Hayman, D J Inwards, M Q Lacy, I N Micallef, L F Porrata & M R Litzow

Authors
  1. M A Elliott
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A Tefferi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. W J Hogan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. L Letendre
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. D A Gastineau
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S M Ansell
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. A Dispenzieri
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. M A Gertz
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. S R Hayman
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. D J Inwards
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. M Q Lacy
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. I N Micallef
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. L F Porrata
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. M R Litzow
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M A Elliott.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Elliott, M., Tefferi, A., Hogan, W. et al. Allogeneic stem cell transplantation and donor lymphocyte infusions for chronic myelomonocytic leukemia. Bone Marrow Transplant 37, 1003–1008 (2006). https://doi.org/10.1038/sj.bmt.1705369

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1705369

Keywords

This article is cited by

Search

Advanced search

Quick links